Evidence map›Paper›PMID 25798919›Full record

ArticlePloS one2015

Genome-wide transcript profiling reveals novel breast cancer-associated intronic sense RNAs.

Sang Woo Kim, Elane Fishilevich, Gustavo Arango-Argoty, Yuefeng Lin, Guodong Liu, Zhihua Li, A Paula Monaghan, Mark Nichols, Bino John

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Stable intronic sequence RNAs (sisRNAs): a new layer of gene regulation.Cellular and molecular life sciences : CMLS · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Sang Woo KimUniversity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15260, United States of America.
Elane FishilevichUniversity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15260, United States of America.
Gustavo Arango-ArgotyUniversity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15260, United States of America.
Yuefeng LinUniversity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15260, United States of America.
Guodong LiuUniversity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15260, United States of America.
Zhihua LiUniversity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15260, United States of America.
A Paula MonaghanDepartment of Neurobiology, University of Pittsburgh, 3501 Fifth Ave, Pittsburgh, Pennsylvania 15260, United States of America.
Mark NicholsDepartment of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15260, United States of America.
Bino JohnUniversity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15260, United States of America.
University of Pittsburgh · US

Funding

Evolution, Biogenesis, and Function of microRNAsR01GM079756 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN, BINO · 2007 to 2011
$1.5M
Natural Mutation at the Coactivator Binding Site of ERR21DK059516 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI NICHOLS, MARK D · 2001 to 2002
$300k
RECEPTOR FUNCTION IN BREAST CANCERS WITH HIGH ER PROTEINR21CA087414 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI NICHOLS, MARK D · 2000 to 2001
$225k
NIGMS NIH HHS GM079756NIGMS NIH HHS R01 GM079756
6 · The paper itself

Abstract

Non-coding RNAs (ncRNAs) play major roles in development and cancer progression. To identify novel ncRNAs that may identify key pathways in breast cancer development, we performed high-throughput transcript profiling of tumor and normal matched-pair tissue samples. Initial transcriptome profiling using high-density genome-wide tiling arrays revealed changes in over 200 novel candidate genomic regions that map to intronic regions. Sixteen genomic loci were identified that map to the long introns of five key protein-coding genes, CRIM1, EPAS1, ZEB2, RBMS1, and RFX2. Consistent with the known role of the tumor suppressor ZEB2 in the cancer-associated epithelial to mesenchymal transition (EMT), in situ hybridization reveals that the intronic regions deriving from ZEB2 as well as those from RFX2 and EPAS1 are down-regulated in cells of epithelial morphology, suggesting that these regions may be important for maintaining normal epithelial cell morphology. Paired-end deep sequencing analysis reveals a large number of distinct genomic clusters with no coding potential within the introns of these genes. These novel transcripts are only transcribed from the coding strand. A comprehensive search for breast cancer associated genes reveals enrichment for transcribed intronic regions from these loci, pointing to an underappreciated role of introns or mechanisms relating to their biology in EMT and breast cancer.

Indexed as

IntronsTranscriptomeAnimalsBasic Helix-Loop-Helix ProteinsBone Morphogenetic Protein ReceptorsBreast NeoplasmsCase-Control StudiesCell Line, TumorDNA-Binding ProteinsEndothelial PAS Domain-Containing Protein 1FemaleGene Expression ProfilingGene Expression Regulation, NeoplasticGenome-Wide Association StudyHomeodomain ProteinsHumansBasic Helix-Loop-Helix ProteinsBone Morphogenetic Protein ReceptorsCRIM1 protein, humanDNA-Binding ProteinsEndothelial PAS Domain-Containing Protein 1Homeodomain ProteinsMembrane ProteinsRBMS1 protein, humanRegulatory Factor X Transcription FactorsRepressor ProteinsRFX2 protein, humanRNA-Binding ProteinsRNA, MessengerTranscription FactorsZEB2 protein, humanZinc Finger E-box Binding Homeobox 2

Identifiers

PMID25798919
PMCPMC4370647
OpenAlexW2095217206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.